CanSino Biologics Inc. CASBF
Set alert
3.41 USD 0.00 0.00%
At close · Oct 30
3.41 Day range 3.55
2.60 52-week range 5.60
- YTD
- -28.06%
- 1 year
- -39.11%
- Open
- 3.55
- Prev close
- 3.41
- Mkt cap
- 842.42M
- Vol
- 1.30K
- Avg vol
- 117
- EPS
- 0.02
- P/E
- 170.50
More statistics
- Low
- 3.41
- High
- 3.55
3M chart
Signals (17)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 28, 2026 | 4 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| MACD: Buy Signal | Oct 1, 2026 | 1 month ago |
| RSI: Overbought | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| RSI: Oversold | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 20, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Apr 28, 2026 | Mar 31, 2026 | — | -0.02319 | — | — |
| Mar 30, 2026 | Dec 31, 2025 | 0.04416 | 0.00776 | -0.04 | -82.43% |
| Oct 27, 2025 | Sep 30, 2025 | -0.00065 | 0.01545 | +0.02 | +2,476.92% |
| Aug 20, 2025 | Jun 30, 2025 | -0.01119 | -0.00088 | +0.01 | +92.14% |
| Apr 29, 2025 | Mar 31, 2025 | -0.0002 | -0.00687 | -0.01 | -3,335.00% |
News
- CanSinoBIO at WGS 2026: Accelerating Global Access to Innovative Vaccines
- CanSino Biologics CEO on earnings, business outlook, and international partnerships
- Riding Covid Vaccine Highs, CanSino Plans Swiss Listing
- Why Is CanSino Biologics (CASBF) Stock Soaring Today?
- China's CanSinoBIO H1 revenue drops on weaker COVID shot demand
- COVID shot drives CanSinoBIO's first six-month profit since at least 2019
- Pandemic Accelerates China's Drive Into mRNA Treatments
Your note
Sign in to keep a note on CASBF — it syncs with the Stock Master app.